Accessibility Menu
Institute Of Biomedical Research logo

Institute Of Biomedical Research(OTC) MRES

Market Cap$3.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-96%
1 Year-88%
1 Month-8%
$0.00
-21.43%
-0.00Today
Institute Of Biomedical Research last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-10
Institute Of Biomedical Research stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.33%USD 0.002026-07-30
1 month-8.33%USD 0.002026-07-10
3 month-11.29%USD 0.002026-05-11
Year to date-60.71%USD 0.002025-12-31
1 year-87.78%USD 0.012025-08-08
3 year-93.56%USD 0.022023-08-11
5 year-95.99%USD 0.032021-08-11
Since inception-99.98%USD 6.002005-09-01

Institute Of Biomedical Research Financials at a Glance

Market Cap

$3.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$25.00K

Net Income (TTM)

-$1.06M

EPS (TTM)

-$0.00

P/E Ratio

-2.75

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.00

Volume

4,387,520

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

MRES News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Institute Of Biomedical Research

Institute of Biomedical Research Corp. is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company focuses on scientific investigation, research and development for new biomedical products, and innovative diagnostic methods.

Products and Services
  • Manufactures healthcare devices including muscle stimulators and ultrasound equipment
  • Develops microbicidal agents and disinfectant solutions
  • Offers regulatory evaluation and certification services for biomedical products
Growth Outlook
  • Recent quarterly revenue of $25,000 indicates potential for growth
  • Expansion into international markets enhances revenue opportunities
  • Focus on innovative biomedical products aligns with industry trends
Financial Highlights
  • Trailing twelve months (TTM) revenue of $25,000 shows early-stage growth
  • Net income for the latest quarter was -$18,568, reflecting ongoing investment
  • Current ratio of 0.034 indicates a need for improved liquidity management
Institute of Biomedical Research Corp. operates in the biotechnology sector, emphasizing research and development of advanced biomedical technologies. The company has a diverse product portfolio, including healthcare devices and innovative solutions for medical applications. Recent financial data indicates a focus on growth, with a modest revenue stream and ongoing investments in product development. The company’s strategic positioning in international markets and commitment to innovation may present opportunities for future expansion and profitability.
AI Generated • Aug 5, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

4

CEO

Peter Jeffrey Robinson

Website

www.mrescorp.com

Headquarters

Podgorica, DU 81000, ME

MRES Financials

Key Financial Metrics (TTM)

Gross Margin

-39.89%

Operating Margin

-952.13%

Net Income Margin

-4230.84%

Return on Equity

793.96%

Return on Capital

N/A

Return on Assets

-2268.74%

Earnings Yield

-36.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.75B

Volume

4.39M

Avg. Volume

1.20M

Financials (TTM)

Gross Profit

-$9.97K

Operating Income

-$238.03K

EBITDA

-$238.03K

Operating Cash Flow

-$151.59K

Capital Expenditure

$0.00

Free Cash Flow

-$151.59K

Cash & ST Invst.

$18.87K

Total Debt

$0.00

Institute Of Biomedical Research Performance Analysis

Institute Of Biomedical Research annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 29,444N/A
20242024-03-31USD 45,07453.1%
20252025-03-31USD 49,4879.8%
20262026-03-31USD 27,706-44.0%
Institute Of Biomedical Research sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-100.0%
Q32025-12-31N/A
Q42026-03-31N/A
Q12026-06-30N/A
Institute Of Biomedical Research annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.0050.0%
20242024-03-31USD 0.00N/A
20252025-03-31USD -0.00N/A
20262026-03-31USD -0.00166.7%
Institute Of Biomedical Research sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-100.0%
Q32025-12-31N/A
Q42026-03-31N/A
Q12026-06-30-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$25.00K

-9.8%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$3.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$604.86K

N/A

Employees

5

N/A

Net Income

-$18.57K

+98.7%

EBITDA

-$44.30K

+60.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$18.87K

+1156.5%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-22.69%

N/A

Return on Invested Capital

48.01%

N/A

Free Cash Flow

-$5.18K

+94.7%

Operating Cash Flow

-$5.18K

+94.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSITFHadasit Bio-Holdings Ltd
$0.12+0.00%
ISCNFIsracann Biosciences Inc.
$0.00+0.00%
CLYYFCelyad Oncology S.A.
$0.28+0.00%
RVXCFResverlogix Corp.
$0.07+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$97.71+0.00%
SPCXSpace Exploration Technologies
$133.29-0.04%
NVDANvidia
$217.50-0.00%
SMCISuper Micro Computer
$31.60+0.00%

Questions About MRES

What is the current price of Institute Of Biomedical Research?

Institute Of Biomedical Research is trading at $0.00 per share.

What is the 52-week range for Institute Of Biomedical Research?

Over the past 52 weeks, Institute Of Biomedical Research has traded between $0.00 and $0.02.

How much debt does Institute Of Biomedical Research have?

As of the most recent reporting period, Institute Of Biomedical Research reported total debt of $0.00.

How much cash does Institute Of Biomedical Research have on hand?

Institute Of Biomedical Research reported $18.87K in cash and cash equivalents in its most recent financial results.

What is Institute Of Biomedical Research’s dividend yield?

Institute Of Biomedical Research does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services